Timber Pharmaceuticals, Inc. (TMBR)
| Market Cap | 48.02M |
| Revenue (ttm) | 453,810 |
| Net Income (ttm) | -15.26M |
| Shares Out | 15.70M |
| EPS (ttm) | -0.97 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $1.10 |
| Previous Close | $1.27 |
| Change ($) | -0.17 |
| Change (%) | -13.39% |
| Day's Open | 1.26 |
| Day's Range | 1.07 - 1.37 |
| Day's Volume | 5,700,529 |
| 52-Week Range | 0.38 - 5.69 |
- Edward J. Sitar appointed as Lead Independent Director of the Board -
It's never a dull day on the Reddit Penny Stocks subreddit and we're checking in to see what's being talked about the most today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Thursday appeared...
Basking Ridge, NJ, April 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. (NYSE American: TMBR) ("Timber” or the "Company"), a biopharmaceutical company focused on the devel...
50% of patients in the Phase 2b CONTROL study have now been randomized despite COVID-19 disruptions in the trial marketplace
- Extension of agreement with AFT Pharmaceuticals grants Desitin Arzneimittel GmbH exclusive license and supply rights for TMB-002 in Europe -
- Study is Evaluating TMB-001 (Topical Isotretinoin) in Subtypes of Rare Genetic Keratinization Disorder
Timber Pharmaceuticals spiked more than 75% in trading today following a virtual life sciences conference this week. Trading volume in TMBR stock was up more than 1600% on the day.
WOODCLIFF LAKE, N.J., March 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the de...
These penny stocks are companies that have a crucial year ahead in terms of industry turnaround or company specific product development. The post 7 Penny Stocks In a Make-or-Break Year appeared first on...
Dr. Mendelsohn has 20+ Years' Experience in Clinical Development and Medical Affairs
Timber Expects to Submit Investigational New Drug (IND) Application to the FDA in 2022
Call to be held on Thursday, December 17th at 11:00am EST
Presentation on Tuesday December 15th at 10:40am EST
Biopharmx Corp shares spiked higher Tuesday morning after the company announced its Phase 2b trial of BPX-04 for Populopustular Rosacea has met both primary and secondary endpoints and was well tolerated.
About TMBR
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical dermatology company, focused on the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.
| Industry Biotechnology | Founded 2019 |
| Stock Exchange NYSEAMERICAN | Ticker Symbol TMBR |